This study demonstrates the ability of pancreatic carcinoma cells to attract CD34+ cells to the tumor site, and to interfere with those cells' hematopoietic development, by diverting their differentiation toward endothelial cells; these cells can become a component of the tumor vasculature. Here, CD34 is linked to neoplasm.